INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic diseases in humans (1) . With an estimated incidence of 1 in 1000 individuals, ADPKD is the most common genetic cause of renal failure, accounting for 8-10% of end-stage renal disease (2) . The characteristic feature of this disease is R. Palsson et al.: Characterization of Polycystin ADPKD has been linked to three different loci: PKD1 on chromosome 16 (4) , PKD2 on chromosome 4 (5, 6) , and a yet to be mapped PKD3 (7, 8) . Mutations in PKD1 account for about 85-95% of patients suffering from ADPKD and generally cause the more severe form, with an earlier onset of end-stage renal disease (3, 9) . Human PKD1 was identified by positional cloning, and homologs have been found in rodents, fish, and worm (Refs. 10 and 11, and our unpublished observations). PKD 1 transcripts have been found in many tissues including human brain, liver, kidney, and colon (12, 13) . Mutations in the 3' region of human PKD1 were detected in several patients with ADPKD (12, 14, 15) . In humans, but apparently not in rodents, approximately 50 kb of DNA, including all but about 10 kb of the 3' region of PKD 1 is duplicated with >95% sequence homology, centromeric to PKD1 (12) . The duplicated area contains at least four copies of the PKD1 region, encoding three homologous genes, and although these are transcribed, it is not currently known if functional protein(s) are produced.
The protein encoded by the bona fide human PKD1 transcript, polycystin, is 4302/3 amino acids (aa) in length, with 60 potential N-glycosylation sites (14, 15) . It is a putative multispanning membrane protein with a large N-terminal ectodomain containing a unique compilation of known cell adhesion domains. These include two leucine-rich repeats, a C-type lectin domain, and 16 immunoglobulin-like domains. Despite these recognized features, the size and function of this protein are unknown. The biochemical defect(s) that triggers renal cyst formation in ADPKD and the mechanism(s) responsible for its autosomal dominant inheritance are also unknown. Abnormal thickening and disorganization of the tubular basement membrane noted in the early stages of the disease (16) , together with evidence of epithelial dedifferentiation at focal areas of tubular dilatation (17, 18) , suggest a potential role of polycystin in cell and matrix adhesion.
In this report, we determined the molecular mass of polycystin and its localization in normal and diseased tissues using anti-peptide antibodies that also cross-react with the rat protein. Multiple forms of the protein were detected by Western blotting; in particular, one form with a high molecular mass, of 642 kD, was detected in rat brain. In normal fetal and adult kidney epithelium, polycystin exhibits basolateral and apical cell distributions. In contrast, polycystin was located intracellularly in ADPKD cystic kidney epithelium, suggesting a defect in protein trafficking and a potential mechanism by which PKD1 mutations cause disease.
MATERIALS AND METHODS
Generation of Anti-Polycystin Antibodies P1 and P2, 15 Arnaout, unpublished] ) was derived from the 3' single copy region, encoding the putative cytoplasmic C-terminal portion of polycystin. Each of the purified peptides were coupled through a synthetic N-terminal cysteine to keyhole limpet hemicyanin (KLH) and bovine serum albumin (BSA). Two New Zealand white rabbits were immunized with the KLH-coupled peptides. The immune sera reacted strongly by enzyme-linked immunosorbent assay (ELISA) with the respective BSA-coupled peptides (not shown). Anti-peptide antibodies were purified using affinity columns prepared by coupling each peptide to SulfoLink affinity resin (Pierce Chemical Co., Rockford, IL, U.S.A.). Each affinity-purified antibody reacted specifically with its respective BSA-coupled peptide (not shown). Protein concentrations were estimated by measuring absorbance at 280 nm.
Expression of Recombinant Polycystin Peptides
The cDNAs 3A3 (12) Western blotting of rat tissues was carried out as follows: forty 10-mm sections of freshly frozen adult brain tissue and of sagittal hemisections of fetuses across kidney tissue were cut in a cryostat and solubilized in 1 ml of Laemmli sample buffer (19) . Proteins were separated by electrophoresis on a 3-11 % gradient SDS-PAGE under reducing conditions, then electroblotted onto Immobilon-P membrane (Millipore). Freshly frozen human fetal kidney tissues were homogenized with a Dounce tissue homogenizer in icecold lysis buffer (50 mM Tris-HCl pH 7.4, 110 mM NaCl, 1% Triton X-100, 5 mM EDTA, 0.5 mM Na-orthovanadate, 5 mM diisopropylfluorophosphate, 1 mM phenylmethylsulfonylfluoride, 2 mg/ml pepstatin, and Complete proteinase inhibitors; Boehringer-Mannheim, Indianapolis, IN, U.S.A.). The homogenate was incubated on ice for 10 min followed by centrifugation at 10,000 rpm in a Beckmann minicentrifuge at 40C. The soluble proteins were separated in a 3-11 % gradient SDS-PAGE under reducing conditions and then electroblotted. The Immobilon-P membranes were blocked, then incubated with anti-peptide antibodies (each at 5 ,g/ml) for 1 hr at room temperature in the presence or absence of the corresponding immunization peptide (at a 10-fold molar excess). Membranes were then processed as described above.
Immunohistochemistry
Freshly frozen and fixed tissues were cut, respectively, into 5-and 4-mm sections and mounted on Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA, U.S.A.). Immunostaining of cryosections was performed using affinitypurified anti-peptide antibodies. Tissue sections were blocked with 1 % BSA in PBS for 20 min at room temperature. Afterwards, the sections were incubated with each antibody (at 5-10 jig/ml in 1 % BSA) for 1 hr at room temperature or over-night at 4°C, in the absence or presence of a 10-fold molar excess of the corresponding peptide. To expose the "hidden" putative cytoplasmic epitope, the frozen sections were fixed by incubation in 95% ethanol at 40C for 5 min and subsequently denatured by incubation in 6 M urea/0.1 M glycine, pH 3.5, for 1 hr at 4°C (20) . Sections were then blocked with 1% BSA, followed by addition of the primary antibodies. Sec 
RESULTS
Characterization of Anti-Polycystin Antibodies The ability of each affinity-purified antibody to detect the respective peptide in the context of a large fragment of polycystin was determined using Western blotting of recombinant polycystinderived fusion proteins. As shown in Fig. 1 (Fig. 2,  Lane 1) . These bands were competed in the presence of P2 (data not shown). In rat fetal kidneycontaining hemisections, two major specific bands at 415 and 239 kD were seen. In addition, fainter bands at 139 and 211 kD, and a variable band at 312 kD were observed (Fig. 2, Lanes 2  and 3 ). These bands disappeared in the presence of the P2 peptide (Fig. 2, Lane 4) . The 415-and 211-kD species were also visualized with API (Fig. 2, Lane 6 ). The faintness of the 415-kD band detected with API may reflect inadequate renaturation of the internal P1 epitope in the highmolecular weight forms of polycystin. In rat fetal kidney tissue, API also reacted with three additional bands of about 271, 194, and 109 kD (Fig. 2 (Fig. 3a) . There was weak staining of the basal surface of S-shaped (Fig. 3a) and comma-shaped bodies (not shown), and of (Fig. 3b) , identical to that seen in rat fetal kidneys. Examination by confocal microscopy showed the staining to be associated with the basolateral membrane of visceral epithelial cells (not shown). Faint staining was observed in the apical and lateral surfaces of parietal epithelium (Fig. 3b , and data not shown). In all cases, staining was abolished in the presence of the P1 peptide (data not shown). AP2 did not result in any staining in rat or human tissues under these standard conditions. However, when these tissues were denatured with 6 M urea, specific staining of collecting duct epithelium was seen ( Fig. 3c and data (Fig. 4 a-c) as well as in noncystic tubules (not shown). A similar pattern was seen in denatured ADPKD kidney tissue using AP2 (Fig. 4d) . Little staining was observed in glomer- uli, which were largely sclerosed (not shown). In contrast to normal tissues, most of the staining in cystic epithelium from fresh frozen tissue was intracellular (Fig. 4 a and b) . This was confirmed by examining API-stained normal and cyst-lining epithelium by confocal microscopy (Fig. 4 e and f). While polycystin was associated with the surface membrane in normal human fetal collecting duct epithelium, it was largely cytoplasmic in ADPKD cyst-lining epithelium and was clustered and most intense in the perinuclear area (Fig. 4f) . Evidence that the immunoreactivity of API and AP2 represents the identification of polycystin in rat and human tissues is based on the following observations. First, affinity-purified anti-peptide antibodies were used that recognize specific polycystin-derived recombinant fusion proteins ( Fig. 1) and are directed against highly conserved epitopes in human and rodent polycystin. Both peptides also lie outside the region that is homologous with the recently cloned PKD2 protein (23) . Second, both antibodies reacted with collecting duct epithelium and demonstrated strong reactivity with cyst-lining ADPKD epithelium, which agrees with previous reports (13, 24) . Third, the collecting duct staining patterns clearly differed between developing and mature renal tissues, consistent with other data showing that expression of PKD1 is developmentally regulated (12, 24) . Fourth, the observed immunoreactivity in tissues is also consistent with one form of polycystin being membraneassociated, with a readily accessible P1 peptide and a presumed intracellular P2 peptide that is exposed only after tissue denaturation.
In humans, but not in rodents, a major part of PKD1 is duplicated, and the duplicated area appears to encode three genes that share substantial homology with PKD1 (12, 15) . Each of these genes produces a polyadenylated transcript, and all have conserved 3' regions that differ from PKD1. The pattern of reactivity of AP1, which recognizes a peptide encoded by the duplicated segment of human PKD1, was strikingly similar in both rat and human fetal kidney tissues (Fig. 2, Lanes 6 and 7) . One interpretation of this finding is that the PKD1 homolog transcripts are not translated into proteins in humans. Alternatively, the protein homologs may be present in amounts too small to be detectable or are expressed in other tissues not examined here.
In rat and human fetal kidneys, polycystin was abundantly expressed basolaterally and apically in ureteric bud and collecting tubule epithelia, and basolaterally in the visceral epithelium of developing glomeruli (Fig. 3) . It was weakly expressed in glomerular parietal epithelium. The prominent basolateral staining observed in some sections (Fig. 3a) and in rat skin (not shown) suggests that some component of polycystin is released from the cell surface, as shown in HT29 cells. In human adult kidneys, polycystin was still detectable in glomeruli and prominent in the intercalated cells of collecting ducts. Strong expression of polycystin in fetal renal tubular epithelium has also been found in two recent studies (13, 24 In normal fetal and adult collecting ducts, polycystin displayed a cell surface-associated distribution (Fig. 3) , consistent with its predicted membrane-spanning regions (14, 15) . In developing rat kidney, intense staining was observed basolaterally in ureteric buds, whereas apical staining of this tissue was predominant in human fetal kidney. This difference may reflect species differences and/or redistribution of the antigen secondary to the unavoidable delay in processing of human fetal tissue. The primary sequence of polycystin reveals several domains known to mediate cell-cell and cell matrix adhesion in other proteins. The basolateral distribution of polycystin in normal collecting duct epithelium supports a putative cell-matrix adhesion function(s) for this protein in epithelia. Its apical distribution does not exclude a role for polycystin in adhesion, since some adhesion proteins may be expressed apically in epithelia under certain conditions (25) (26) (27) . Polycystin may also serve a transport function in apical membranes, a role suggested recently by the significant homology of the C-terminal region of polycystin to the PKD2 protein and to a voltage-activated sodium channel (23) . These putative functions are probably not essential for epithelial development, since formation of kidneys is initially normal in ADPKD, but may be essential in the maintenance and remodeling of already formed epithelium.
Expression of polycystin was increased in the epithelial lining of renal cysts in ADPKD. This observation agrees with that recently reported by Ward et al. and Griffin et al. (13, 24) in patients with ADPKD 1 (but not ADPKD2 or acquired renal cystic disease). Significantly, we found that polycystin was largely cytoplasmic in the epithelial lining of cysts (Fig. 4) , in contrast to its predominantly surface membrane-associated localization in normal fetal and adult kidney epithelium (Fig. 3) . Ward et al. has shown that in ADPKD increased quantities of the wild-type as well as the mutant alleles are expressed (13) . The minimal surface expression of polycystin in ADPKrD cyst-lining epithelium suggests, therefore, that the normal allele is unable to reach the cell surface in sufficient amounts to mediate its functions. Functional loss of polycystin from the cell surface may therefore be a likely mechanism by which mutations in the PKD1 gene cause disease, at least in some patients. Formation of a nonfunctional complex between the wild-type and mutant alleles may be one mechanism for deficient surface expression. The cyst-lining epithelium in ADPKD expresses embryonic genes and proteins. It also displays a reversed polarity of several of its membrane proteins and a delay in the exit of some surface components from the Golgi (18, 28) . These alterations may involve interactions of the mutant polycystin with as yet uncharacterized intracellular proteins.
